Table 3.

Multivariate analyses of predictors of inferior postoperative survivala

Hazard Ratio (95% CI)P
Extent of resection: GTR vs incomplete0.42 (0.21–0.85).015
Age at study entry: 18–54 vs 55+ y1.25 (0.65–2.41).508
MGMT promoter: methylated vs unmethylated0.58 (0.30–1.11).100
KPS at study entry: 90%–100% vs KPS 50%–80%0.82 (0.43–1.54).528
Steroids at study entry: no vs yes0.82 (0.42–1.62).566
Hazard Ratio (95% CI)P
Extent of resection: GTR vs incomplete0.42 (0.21–0.85).015
Age at study entry: 18–54 vs 55+ y1.25 (0.65–2.41).508
MGMT promoter: methylated vs unmethylated0.58 (0.30–1.11).100
KPS at study entry: 90%–100% vs KPS 50%–80%0.82 (0.43–1.54).528
Steroids at study entry: no vs yes0.82 (0.42–1.62).566

Abbreviations: GTR, gross total resection; MGMT, O6-methylguanine DNA methyltransferase.

a

Patients with complete clinical and imaging data (n = 52).

Table 3.

Multivariate analyses of predictors of inferior postoperative survivala

Hazard Ratio (95% CI)P
Extent of resection: GTR vs incomplete0.42 (0.21–0.85).015
Age at study entry: 18–54 vs 55+ y1.25 (0.65–2.41).508
MGMT promoter: methylated vs unmethylated0.58 (0.30–1.11).100
KPS at study entry: 90%–100% vs KPS 50%–80%0.82 (0.43–1.54).528
Steroids at study entry: no vs yes0.82 (0.42–1.62).566
Hazard Ratio (95% CI)P
Extent of resection: GTR vs incomplete0.42 (0.21–0.85).015
Age at study entry: 18–54 vs 55+ y1.25 (0.65–2.41).508
MGMT promoter: methylated vs unmethylated0.58 (0.30–1.11).100
KPS at study entry: 90%–100% vs KPS 50%–80%0.82 (0.43–1.54).528
Steroids at study entry: no vs yes0.82 (0.42–1.62).566

Abbreviations: GTR, gross total resection; MGMT, O6-methylguanine DNA methyltransferase.

a

Patients with complete clinical and imaging data (n = 52).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close